论文部分内容阅读
我科收治 1例急性髓细胞性白血病(AML- M2 a)患者 ,持续完全缓解 (CR) 11月 ,外周血干细胞动员失败后行 HL A半相合混合骨髓移植 (MBMT) ,移植后短期复发 ,经化疗后获得完全缓解(CR2 ) ,后行供者淋巴细胞输注 (DL I) ,DL I后 2 0天白血病复发 ,现报道如下。1 病例与方法1.1
One patient with acute myeloid leukemia (AML-M2a) was treated in our department for continuous complete remission (CR). In November, HLM haploidentical mixed bone marrow transplantation (MBMT) was performed after failed to mobilize peripheral blood stem cells. Short- After chemotherapy to obtain complete remission (CR2), followed by donor lymphocyte infusion (DLI), 20 days after DLI leukemia relapse, are reported below. 1 cases and methods 1.1